AccuPlex4

Introducing the New Standard for
Canine Vector Borne Disease Screening

The AccuPlex4 test for heartworm and the pathogens that cause Lyme disease, ehrlichiosis and anaplasmosis offers significant improvements in sensitivity and specificity over existing screening tests.

The advantages of AccuPlex4 include:

Earlier Detection of Tick Borne Infections: AccuPlex4 detected tick-borne infections (Borrelia burgdorferi, Anaplasma and Ehrlichia) one to two weeks earlier on average than SNAP® 4Dx® in a recent study.

More Sensitive Heartworm Detection: AccuPlex4 detected 100% of 1-2 worm infections in a recent study compared to a 75% detection rate previously reported for SNAP® Heartworm.

Comprehensive Lyme Testing: AccuPlex4 detects and differentiates between natural exposure and vaccination to Borrelia burgdorferi, and differentiates between early and chronic infections.

Better Value for Your Hospital: With AccuPlex4, you receive free re-checks of your original submission upon request. Plus you’ll reap savings from reducing your pet-side test inventory, avoiding expired tests and saving precious staff time.

Made Possible by ANTECH™ Bio-CD Technology

The AccuPlex4 test is run on the ANTECH™ Bio-CD, an innovative diagnostic platform for the veterinary industry available exclusively from ANTECH Diagnostics. The Bio-CD uses a combination of laser beams and fluorescence to detect antibodies and natural or artificial peptides on the silicon disc surface. Just as a DVD player uses laser beams to scan microscopic grooves on a spinning disc and convert them into digital information, the BioCD converts fluorescence and laser deflection signals from biological samples into laboratory data. Adapted from technology developed by researchers at Purdue university, the BioCD platform gives ANTECH the capability to run multiplex assays on a single sample of serum.

The AccuPlex4 test uses a combination of eight separate natural and artificial peptides and antibodies to detect:

Dirofilaria immitis antigen (heartworm)
Ehrlichia canis antibodies
Anaplasma phagocytophilum antibodies
Lyme disease: 5 different antibody responses to natural and artificial peptides of Borrelia burgdorferi which differentiate natural exposure, early vs. later stage infections and vaccination.

The Bio-CD platform’s unique multiplexing ability allows ANTECH to run multiple markers on a single sample and embed positive and negative controls with each and every patient sample. More specifically, the technology enables ANTECH to detect antibody response to five distinct Lyme targets, providing the most comprehensive information on response to B. burgdorferi exposure or vaccination. The end result is more accurate exposure/infection detection, markedly improved sensitivity over ELISA and IFA tests, and more information extracted from a single patient sample.

The AccuPlex4 test’s combination of earlier, more accurate detection and additional clinically important data offers veterinarians a better choice for vector borne disease screening.

AccuPlex4 Ordering Information